Assessment of anti-angiogenic therapies for the most severe form of brain cancer, glioblastoma, is extremely timely given the recent approval of bevacizumab yet the moderate response rate and the challenging side effects of these therapies. Clinical decision-making tools are badly needed;fortunately, our recently published data suggest that measurement of microvascular properties of the tumor using MRI and gadolinium-based approaches could be very useful, as with proper quantitation these methods appear to be capable of serving as an effective prognostic imaging biomarker, and may be beneficially combined with blood biomarkers. We propose to join the NCI's Quantitative Imaging Network (QIN) and develop improved analysis methods for dynamic contrast enhanced MRI and dynamic susceptibility MRI that will improve quantification and decrease variability. We propose to develop techniques that will be applicable in the multicenter setting through a bottom-up approach of simulations, phantom studies, retrospective analysis, and prospective analysis in patients undergoing treatment with anti-angiogenic therapies. We anticipate that our proposed approach, in particular through working in close harmony with the QIN, will improve the reliability of advanced microvascular MRI methods as potential imaging biomarkers, and pave the way for a clinically useful decision-making tool.
Advanced MRI methods may improve our ability to provide an accurate prognosis and potentially guide treatment choices for glioblastoma patients. Our proposed research will help establish a common, standardized approach to acquisition and analysis of two forms of vascular MRI that have shown excellent promise. We will do this by careful reduction of variability and by close participation in the National Cancer Institute's Quantitative Imaging Network. These efforts will enable these advanced techniques to become more widely available and more appropriately establish their benefit to patients.
|Obuchowski, Nancy A; Reeves, Anthony P; Huang, Erich P et al. (2015) Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons. Stat Methods Med Res 24:68-106|
|Obuchowski, Nancy A; Barnhart, Huiman X; Buckler, Andrew J et al. (2015) Statistical issues in the comparison of quantitative imaging biomarker algorithms using pulmonary nodule volume as an example. Stat Methods Med Res 24:107-40|
|Kalpathy-Cramer, Jayashree; de Herrera, Alba García Seco; Demner-Fushman, Dina et al. (2015) Evaluating performance of biomedical image retrieval systems--an overview of the medical image retrieval task at ImageCLEF 2004-2013. Comput Med Imaging Graph 39:55-61|
|Chenevert, Thomas L; Malyarenko, Dariya I; Newitt, David et al. (2014) Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. Transl Oncol 7:65-71|
|Kalpathy-Cramer, Jayashree; Gerstner, Elizabeth R; Emblem, Kyrre E et al. (2014) Advanced magnetic resonance imaging of the physical processes in human glioblastoma. Cancer Res 74:4622-37|
|Jafari-Khouzani, Kourosh (2014) MRI upsampling using feature-based nonlocal means approach. IEEE Trans Med Imaging 33:1969-85|
|Kalpathy-Cramer, Jayashree; Freymann, John Blake; Kirby, Justin Stephen et al. (2014) Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive. Transl Oncol 7:147-52|
|Gutman, David A; Dunn Jr, William D; Cobb, Jake et al. (2014) Web based tools for visualizing imaging data and development of XNATView, a zero footprint image viewer. Front Neuroinform 8:53|
|Huang, Wei; Li, Xin; Chen, Yiyi et al. (2014) Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge. Transl Oncol 7:153-66|
|Kalpathy-Cramer, Jayashree; Awan, Musaddiq; Bedrick, Steven et al. (2014) Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison. J Digit Imaging 27:108-19|
Showing the most recent 10 out of 12 publications